224 related articles for article (PubMed ID: 18487861)
1. [Organization, administration, and performance of clinical studies].
Bachner M; Steininger T; Gneist M
Onkologie; 2008; 31 Suppl 2():3-6. PubMed ID: 18487861
[TBL] [Abstract][Full Text] [Related]
2. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
Englev E; Petersen KP
Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
[TBL] [Abstract][Full Text] [Related]
3. [Limitations and pitfalls of clinical studies in oncology].
Cerny T
Onkologie; 2008; 31 Suppl 2():67-71. PubMed ID: 18487873
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the compliance of informed consent documents with good clinical practice guideline.
Padhy BM; Gupta P; Gupta YK
Contemp Clin Trials; 2011 Sep; 32(5):662-6. PubMed ID: 21664297
[TBL] [Abstract][Full Text] [Related]
5. [Audit of clinical trials in Argentina. Assessment of standardized operational procedures in 12 centers].
Forti IN; Barousse AP; Bernabó JG
Medicina (B Aires); 1991; 51(6):511-8. PubMed ID: 7476103
[TBL] [Abstract][Full Text] [Related]
6. [Pharmaceutical aspects of clinical trials: concepts of pharmacokinetic investigations].
Czejka M
Onkologie; 2008; 31 Suppl 2():29-33. PubMed ID: 18487866
[TBL] [Abstract][Full Text] [Related]
7. [The inspection by the Danish Medical Products Agency of drug clinical trials].
Jacobsen E; Stilbo I
Ugeskr Laeger; 2003 Apr; 165(16):1656-8. PubMed ID: 12756822
[TBL] [Abstract][Full Text] [Related]
8. [Public GCP unit--experiences from the Aarhus University Hospital].
Jørgensen A; Rønnow IL; Nexø E
Ugeskr Laeger; 2003 Apr; 165(16):1667-9. PubMed ID: 12756826
[TBL] [Abstract][Full Text] [Related]
9. [Data documentation and data management with guidelines, experiences, caveats, and recommendations].
Edler L; Pilz LR
Onkologie; 2008; 31 Suppl 2():7-13. PubMed ID: 18487862
[TBL] [Abstract][Full Text] [Related]
10. [Biostatistical issues].
Hudec M
Onkologie; 2008; 31 Suppl 2():14-20. PubMed ID: 18487863
[TBL] [Abstract][Full Text] [Related]
11. [New Japanese GCP--from the standpoint of a sponsor].
Ebi O
Gan To Kagaku Ryoho; 1998 Apr; 25(5):650-62. PubMed ID: 9571962
[TBL] [Abstract][Full Text] [Related]
12. Current status of quality in Japanese clinical trials.
Saito K; Kodama Y; Ono S; Mutoh M; Kawashima S; Fujimura A
Contemp Clin Trials; 2005 Aug; 26(4):503-9. PubMed ID: 16054582
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacy Department standard procedures for clinical trial development].
Pérez Peiró C; Porta Oltra B; Cholvi Llovell M; Jiménez Torres NV
Farm Hosp; 2004; 28(1):36-47. PubMed ID: 15012177
[TBL] [Abstract][Full Text] [Related]
14. [The GCP directive--consequences for clinical drug research].
Gluud CN
Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of clinical trials by Ethics Committees in Germany--results and a comparison of two surveys performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
Russ H; Busta S; Jost B; Bethke TD
Ger Med Sci; 2015; 13():Doc02. PubMed ID: 25698912
[TBL] [Abstract][Full Text] [Related]
16. A comparative method of evaluating quality of international clinical studies in China: Analysis of site visit reports of the Clinical Research Operations and Monitoring Center.
Chang JJ; Xu J; Fan D
Contemp Clin Trials; 2008 Sep; 29(5):654-62. PubMed ID: 18450522
[TBL] [Abstract][Full Text] [Related]
17. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
18. [Standards, guidelines and principles for clinical trials: medical products].
Ziegler WJ; Perren SM
Swiss Surg; 1995; (1):81-3. PubMed ID: 8581810
[TBL] [Abstract][Full Text] [Related]
19. Longer consent forms for clinical trials compromise patient understanding: so why are they lengthening?
Beardsley E; Jefford M; Mileshkin L
J Clin Oncol; 2007 Mar; 25(9):e13-4. PubMed ID: 17369564
[No Abstract] [Full Text] [Related]
20. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
